
Afana Biotechnology
Afana Biotechnology is a company that provides research and development for mRNA technology, sequence optimization, and delivery systems.
$50M Series A ·
Led by Anhui High-tech Industry Investment · Source: news.pedaily.cn
Funding history ↓Signals
Website registeredJul 13, 2021 (5 years old)
Funding rounds
- Series A · $50MAAnhui High-tech Industry Investment (lead),
GGaozheng Chuangtou (lead),
HHefei Industrial Investment Guozheng Equity Investment (lead),
SShenzhen Guozhong Venture Capital Management (lead),
EEternale Funds, HHefei Industrial Investment Promotion Phase II Venture Capital Fund, HHongjing Chuangtou, SShanghai Qinda Investment Holding Group
Source: news.pedaily.cn - Website created
Investors
- AAnhui High-tech Industry Investmentlead investor
EEternale Funds
GGaozheng Chuangtoulead investor
GGuoyuan Securities
HHefei Industrial Investment Guozheng Equity Investmentlead investor
- HHefei Industrial Investment Promotion Phase II Venture Capital Fund
- HHongjing Chuangtou
- SShanghai Qinda Investment Holding Group
SShenzhen Guozhong Venture Capital Managementlead investor
Companies like Afana Biotechnology
RReCode TherapeuticsSeries B+ · Oct 2023SSensible Biotechnologies$47M Series A · Oct 2026
AAllerGene AI TherapeuticsSeed · Jun 2026
IInnornaSeries B+ · Apr 2022LLiving Models$7M Seed · Mar 2026
AAxelyfSeed · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/afana-biotechnology (get a free API key).